Top

Journal of Autism and Developmental Disorders

Gepubliceerd in:

01-01-2009 | Original Paper

Cortical Serotonin Type-2 Receptor Density in Parents of Children with Autism Spectrum Disorders

Auteurs: Jeremy Goldberg, George M. Anderson, Lonnie Zwaigenbaum, Geoffrey B. C. Hall, Claude Nahmias, Ann Thompson, Peter Szatmari

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 1/2009

Abstract

Parents (N = 19) of children with autism spectrum disorders (ASD) and adult controls (N = 17) underwent positron emission tomography (PET) using [¹⁸F]setoperone to image cortical serotonin type-2 (5-HT2) receptors. The 5-HT2 binding potentials (BPs) were calculated by ratioing [¹⁸F]setoperone intensity in regions of interest (ROI) to cerebellar intensity. Cortical 5-HT2 BPs were significantly lower in parents compared to controls and platelet 5-HT levels were significantly negatively correlated with cortical 5-HT2 BP in parents. Lower cortical 5-HT2 receptor density in parents of children with ASD is consistent with reports of diminished 5-HT2 expression and functioning in individuals with ASD. Further research should examine the relationship of reduced 5-HT2 receptor expression to underlying causation and to clinical and neurochemical correlates of autistic behavior.

vorige artikel Joint Engagement and the Emergence of Language in Children with Autism and Down Syndrome

volgende artikel The Use of Weighted Vests with Children with Autism Spectrum Disorders and Other Disabilities

American Psychiatric Press. (1994). Diagnostic and statistical manual of mental disorders 4th edition (DSM-IV). Washington, DC: American Psychiatric Association.

Anderson, G. M. (2002). Genetics of childhood disorders: XLV. Autism, Part 4: Serotonin in autism. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1513–1516. doi:10.1097/00004583-200212000-00025.PubMedCrossRef

Anderson, G. M., Feibel, F. C., & Cohen, D. J. (1987). Determination of serotonin in whole blood, platelet-rich plasma, platelet-poor plasma and plasma ultra-filtrate. Life Sciences, 40, 1063–1070. doi:10.1016/0024-3205(87)90568-6.PubMedCrossRef

Arranz, B., Eriksson, A., Mellerup, E., Plenge, P., & Marcusson, J. (1993). Effect of aging on human cortical pre and post synaptic serotonin binding sites. Brain Research, 620, 163–166. doi:10.1016/0006-8993(93)90286-V.PubMedCrossRef

Bailey, A., Le Couteur, A., Gottesman, I., Bolten, P., Simonoff, E., Yuzda, E., et al. (1995). Autism is a strongly genetic disorder: Evidence from a British twin study. Psychological Medicine, 25, 63–77.PubMedCrossRef

Baron-Cohen, S., Knickmeyer, R. C., & Belmonte, M. K. (2005). Sex differences in the brain: Implications for explaining autism. Science, 310, 819–823. doi:10.1126/science.1115455.PubMedCrossRef

Baron-Cohen, S., Ring, H., Chitnis, X., Wheelwright, S., Gregory, L., et al. (2006). fMRI of parents of children with Asperger’s Syndrome: A pilot study. Brain and Cognition, 61, 122–130. doi:10.1016/j.bandc.2005.12.011.PubMedCrossRef

Bhagwagar, Z., Hinz, R., Taylor, M., Fancy, S., Cowen, P., & Grasby, P. (2006). Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [(11)C]MDL 100, 907. The American Journal of Psychiatry, 163, 1580–1587. doi:10.1176/appi.ajp. 163.9.1580.PubMedCrossRef

Blin, J., Sette, G., Fiorelli, M., Bletry, O., Elghozi, J. L., et al. (1990). A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. Journal of Neurochemistry, 54, 1744–1754. doi:10.1111/j.1471-4159.1990.tb01229.x.PubMedCrossRef

Bolton, P., Macdonald, H., Pickles, A., Rios, P., Goode, S., Crowson, M., et al. (1994). A case–control family history study of autism. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 35, 877–900. doi:10.1111/j.1469-7610.1994.tb02300.x.PubMedCrossRef

Bonnin, A., Torii, M., Wang, L., Rakic, P., & Levitt, P. (2007). Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nature Neuroscience, 10, 588–597. doi:10.1038/nn1896.PubMedCrossRef

Burnet, P. W., Eastwood, S. L., & Harrison, P. J. (1996). 5-HT1A and 5-HT2A receptor mRNAs and binding densities are differentially altered in schizophrenia. Neuropsychophamacology, 15, 422–455.

Chandana, S. R., Behen, M. E., Juhasz, C., Muzik, O., Rothermel, R. D., Mangner, T. J., et al. (2005). Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. International Journal of Developmental Neuroscience, 23, 171–182. doi:10.1016/j.ijdevneu.2004.08.002.PubMedCrossRef

Cho, I. H., Yoo, H. J., Park, M., Lee, Y. S., & Kim, S. A. (2008). Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Research, 1139, 34–41. doi:10.1016/j.brainres.2007.01.002.CrossRef

Constantino, J. N., Davis, S. A., et al. (2003). Validation of a brief quantitative measure of autistic traits: Comparison of the social responsiveness scale with the autism diagnostic interview-revised. Journal of Autism and Developmental Disorders, 33, 427–433. doi:10.1023/A:1025014929212.PubMedCrossRef

Cook, E. H., Jr, Arora, R. C., Anderson, G. M., Berry-Kravis, E. M., Yan, S. Y., Yeoh, H. C., et al. (1993). Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sciences, 52, 2005–2015. doi:10.1016/0024-3205(93)90685-V.PubMedCrossRef

Crouzel, C., Venet, M., Irie, G., Sanz, G., & Boullais, C. (1988). Labeling of a serotonergic ligand with 18-F Setoperone. Journal of Labelled Compounds and Radiopharmaceuticals, 25, 403–414. doi:10.1002/jlcr.2580250407.CrossRef

Danaceau, J. P., Anderson, G. M., McMahon, W. M., & Crouch, D. J. (2003). A liquid chromatographic-tandem mass spectrometric method for the analysis of serotonin and related indoles in human whole blood. Journal of Analytical Toxicology, 27, 440–444.PubMed

Duvall, J. A., Lu, A., et al. (2007). A quantitative trait locus analysis of social responsiveness in multiplex autism families. The American Journal of Psychiatry, 164, 656–662. doi:10.1176/appi.ajp. 164.4.656.PubMedCrossRef

Eison, A. S., & Mullins, U. L. (1996). Regulation of central 5HT2A receptors: A review of in vivo studies. Behavioural Brain Research, 73, 177–181. doi:10.1016/0166-4328(96)00092-7.PubMedCrossRef

Epperson, C. N., Czarkowski, K. A., Ward-O’Brien, D., Weiss, E., Gueorguieva, R., Jatlow, P., et al. (2001). Maternal sertraline treatment and serotonin transport in breastfeeding mother-infant pairs. The American Journal of Psychiatry, 158, 1631–1637. doi:10.1176/appi.ajp. 158.10.1631.PubMedCrossRef

Fatemi, S. H., Stary, J. M., & Egan, E. A. (2002). Reduced blood levels of reelin as a vulnerability factor in pathophysiology of autistic disorder. Cellular and Molecular Neurobiology, 22, 139–152. doi:10.1023/A:1019857620251.PubMedCrossRef

Folstein, S. & Rutter, M. (1991). Family history interview for developmental disorders of cognition and social functioning (available from authors).

Folstein, S. E., Santangelo, S. L., Gilman, S. E., Piven, J., Landa, R., Lainhart, J., et al. (1999). Predictors of cognitive test patterns in autism families. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 40, 1117–1128. doi:10.1017/S0021963099004461.PubMedCrossRef

Gotham, K., Risi, S., Pickles, A., & Lord, C. (2007). The Autism Diagnostic Observation Schedule: Revised algorithms for improved diagnostic validity. Journal of Autism and Developmental Disorders, 37, 613–627. doi:10.1007/s10803-006-0280-1.PubMedCrossRef

Gottesman, I. I., & Gould, T. D. (2003). The enodphontype concept in psychiatry: Etymology and strategic intentions. The American Journal of Psychiatry, 160, 636–645. doi:10.1176/appi.ajp. 160.4.636.PubMedCrossRef

Happe, F., Briskman, J., & Frith, U. (2001). Exploring the cognitive phenotype of autism: Weak “central coherence” in parents and siblings of children with autism: I. Experimental tests. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 42, 299–307. doi:10.1017/S0021963001006916.PubMedCrossRef

Happe, F., Ronald, A., & Plomin, R. (2006). Time to give up on a single explanation for autism. Nature Neuroscience, 9, 1218–1220. doi:10.1038/nn1770.PubMedCrossRef

Herault, J., Petit, E., Martineau, J., Cherpi, C., Perrot, A., Barthelemy, C., et al. (1996). Serotonin and autism: Biochemical and molecular biology features. Psychiatry Research, 65, 33–43. doi:10.1016/0165-1781(96)02882-X.PubMedCrossRef

Hurley, R. S., Losh, M., et al. (2007). The broad autism phenotype questionnaire. Journal of Autism and Developmental Disorders, 37, 1679–1690. doi:10.1007/s10803-006-0299-3.PubMedCrossRef

Jakab, R. L., & Goldman-Rakic, P. S. (1998). 5-Hydroxytryptamine serotonin receptors in the primate cerebral cortex: Possible site of action of hallucinogenic and antipsychotic drugs in the pyramidal cell apical dendrites. Proceedings of the National Academy of Sciences of the USA, 95, 735–740. doi:10.1073/pnas.95.2.735.PubMedCrossRef

Janusonis, S., Gluncic, V., & Rakic, P. (2004). Early serotonergic projections to Cajal-Retzius cells: Relevance for cortical development. The Journal of Neuroscience, 24, 1652–1659. doi:10.1523/JNEUROSCI.4651-03.2004.PubMedCrossRef

Kapur, S., Jones, C., DaSilva, J., Wilson, A., & Houle, S. (1997). Reliability of a simple non-invasive method for the evaluation of 5-HT2 receptors using (18F) setoperone PET imaging. Nuclear Medicine Communications, 18, 395–399. doi:10.1097/00006231-199705000-00002.PubMedCrossRef

Kolevzon, A., Mathewson, K. A., & Hollander, E. (2006). Selective serotonin reuptake inhibitors in autism: A review of efficacy and tolerability. The Journal of Clinical Psychiatry, 67, 407–414.PubMedCrossRef

Kugaya, A., Epperson, C. N., Zoghbi, S., van Dyck, C. H., Hou, Y., Fujita, M., et al. (2003). Increase in prefrontal cortex serotonin2A receptors following estrogen treatment in postmenopausal women. The American Journal of Psychiatry, 160, 522–524. doi:10.1176/appi.ajp. 160.8.1522.CrossRef

Lainhart, J. E., Ozonoff, S., Coon, H., Krasny, L., Dinh, E., Nice, J., et al. (2002). Autism, regression, and the broader autism phenotype. American Journal of Medical Genetics, 113, 231–237. doi:10.1002/ajmg.10615.PubMedCrossRef

Laruelle, M., Abi-Dargham, A., Casanova, M. F., Toti, R., Weinberger, D., & Kleinman, J. (1993). Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study. Archives of General Psychiatry, 50, 810–818.PubMed

Leboyer, M., Bellivier, F., Nosten-Bertrand, M., Jouvent, R., Pauls, D., Mallet, J., et al. (1998). Psychiatric genetics: Search for phenotypes. Trends in Neurosciences, 21, 102–105. doi:10.1016/S0166-2236(97)01187-9.PubMedCrossRef

Levine, M. (1986). Leiter international performance scale: A handbook. Los Angeles: Western Psychological Services.

Lewis, R., Kapur, S., Jones, C., DaSilva, J., Brown, G., Wilson, A., et al. (1999). Serotonin 5-HT2 Receptors in Schizophrenia: A PET study using [¹⁸ F] setoperone in neuroleptic-naive patients and normal subjects. The American Journal of Psychiatry, 156, 72–78.PubMed

Lopez-Figueroa, A. L., Norton, C. S., Lopez-Figueroa, M. O., Armellini-Dodel, D., Burke, S., Akil, H., et al. (2004). Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia. Biological Psychiatry, 55, 225–233. doi:10.1016/j.biopsych.2003.09.017.PubMedCrossRef

Lord, C., Rutter, M., & Le Couteur, A. (1994). Autism Diagnostic Interview—Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. Journal of Autism and Developmental Disorders, 24, 659–685. doi:10.1007/BF02172145.PubMedCrossRef

Losh, M., & Piven, J. (2007). Social-cognition and the broad autism phenotype: Identifying genetically meaningful phenotypes. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 48, 105–112. doi:10.1111/j.1469-7610.2006.01594.x.PubMedCrossRef

MacLean, J. E., Szatmari, P., Jones, M. B., Bryson, S. E., Mahoney, W. J., Bartolucci, G., et al. (1999). Familial factors influence level of functioning in pervasive developmental disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 746–753. doi:10.1097/00004583-199906000-00023.PubMedCrossRef

Mann, J. J., Brent, D., & Arango, V. (2001). The neurobiology and genetics of suicide and attempted suicide: A focus on the serotonergic system. Neuropsychopharmacology, 24, 467–477. doi:10.1016/S0893-133X(00)00228-1.PubMedCrossRef

McBride, P. A., Anderson, G. M., Herzig, M., Sweeney, J., Kream, J., Cohen, D. J., et al. (1989). Serotonergic responsivity in male young adults with autistic disorder: Results of a pilot study. Archives of General Psychiatry, 46, 213–221.PubMed

McBride, P. A., Anderson, G. M., & Shapiro, T. (1996). Autism research: Bringing together approaches to pull apart the disorder. Archives of General Psychiatry, 53, 980–983.PubMed

Meltzer, C. C., Price, J. C., Mathis, C. A., Greer, P. J., Cantwell, M. N., Houck, P. R., et al. (1999). PET imaging of serotonin type 2A receptors in late life neuropsychiatric disorders. The American Journal of Psychiatry, 156, 1871–1878.PubMed

Meyer, J., Kapur, S., Houle, S., DaSilva, J., Owczarek, B., Brown, G., et al. (1999). Prefrontal cortex 5-HT2 receptors in depression: An [¹⁸F] setoperone PET imaging study. The American Journal of Psychiatry, 156, 1029–1034.PubMed

Minton, M. A., Sheline, Y. I., Moerlein, S. M., Vlassenk, A. G., Huang, Y., & Snyder, A. Z. (2003). Decreased hippocampal 5-HT2a receptor binding in major depression: In vivo measurement with [¹⁸F]altanserin positron emission tomography. Biological Psychiatry, 55, 217–224. doi:10.1016/j.biopsych.2003.08.015.CrossRef

Mulder, E. J., Anderson, G. M., Kema, I. P., de Bildt, A., van Lang, N. D. J., den Boer, J. A., et al. (2004). Platelet serotonin in pervasive developmental disorders and mental retardation: Diagnostic group differences, within-group distribution and behavioral correlates. Journal of the American Academy of Child and Adolescent Psychiatry, 43, 491–499. doi:10.1097/00004583-200404000-00016.PubMedCrossRef

Murphy, D. G., Schmitz, N., Toal, F., Murphy, K., Daly, E., Erlandsson, K., et al. (2006). Cortical 5-HT2A receptor binding and social communication in adults with Asperger’s syndrome: An in vivo SPECT study. The American Journal of Psychiatry, 163, 934–936. doi:10.1176/appi.ajp. 163.5.934.PubMedCrossRef

Murphy, M., Bolton, P. F., Pickles, A., Fombonne, E., Piven, J., & Rutter, M. (2000). Personality traits of the relatives of autistic probands. Psychological Medicine, 30, 1411–1424. doi:10.1017/S0033291799002949.PubMedCrossRef

Palmen, S. J., Hulshoff Pol, H. E., Kemner, C., Schnack, H. G., Sitskoorn, M. M., Appels, M. C., et al. (2005). Brain anatomy in non-affected parents of autistic probands: A MRI study. Psychological Medicine, 35, 1411–1420. doi:10.1017/S0033291705005015.PubMedCrossRef

Pazos, A., Probst, A., & Palacio, J. M. (1987). Serotonin receptors in the human brain—iv. autoradiographic mapping of serotonin-2 receptors. NeuroImage, 21, 123–139.

Peterson, E., Schmidt, G. L., Tregellas, J. R., Winterrowd, E., Kopelioff, L., Hepburn, S., et al. (2006). A voxel-based morphometry study of gray matter in parents of children with autism. Neuroreport, 17, 1289–1292. doi:10.1097/01.wnr.0000233087.15710.87.PubMedCrossRef

Petit-Tabou, M. C., Landeau, B., Osmont, A., Tillet, I., Barre, L., & Baron, J. C. (1996). Estimation of neo-cortical serotonin-2 receptor binding potential by single dose fluorine-18-Setoperone kinetic PET data analysis. Journal of Nuclear Medicine, 37, 95–104.

Piven, J., Palmer, P., Jacobi, D., Childress, D., & Arndt, S. (1997). Broader autism phenotype: Evidence from a family history study of multiple-incidence autism families. The American Journal of Psychiatry, 154, 185–190.PubMed

Polleux, F., & Lauder, J. M. (2004). Toward a developmental neurobiology of autism. Mental Retardation and Developmental Disabilities Research Reviews, 10, 303–317. doi:10.1002/mrdd.20044.PubMedCrossRef

Rapin, I. (1997). Autism. The New England Journal of Medicine, 337, 97–104. doi:10.1056/NEJM199707103370206.PubMedCrossRef

Rojas, D. C., Smith, J. A., Benkers, T. L., Camou, S. L., Reite, M. L., & Rogers, S. J. (2004). Hippocampus and amygdala volumes in parents of children with autistic disorder. The American Journal of Psychiatry, 161, 2038–2044. doi:10.1176/appi.ajp. 161.11.2038.PubMedCrossRef

Ruser, T. F., Arin, D., Dowd, M., Putnam, S., Winklosky, B., Rosen-Sheidley, B., et al. (2008). Communicative competence in parents of children with autism and parents of children with specific language impairment. Journal of Autism and Developmental Disorders, 37, 1323–1336. doi:10.1007/s10803-006-0274-z.CrossRef

Rutter, M. (1999). Autism: Two-way interplay between research and clinical work. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 40, 169–188. doi:10.1017/S0021963098003461.PubMedCrossRef

Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. The Journal of Pediatrics, 58, 315–320. doi:10.1016/S0022-3476(61)80261-8.PubMedCrossRef

Skuse, D. H. (2001). Endophenotypes and child psychiatry. The British Journal of Psychiatry, 178, 395–396. doi:10.1192/bjp. 178.5.395.PubMedCrossRef

Sparrow, S., Bala, D., & Cichetti, D. (1984). Vineland Adaptive Behaviour Scales (Survey Form). Circle Pines, MN: American Guidance Service.

Stone, W. L., McMahon, C. R., Yoder, P. J., & Walden, T. A. (2008). Early social-communicative and cognitive development of younger siblings of children with autism spectrum disorders. Archives of Pediatrics and Adolescent Medicine, 161, 384–390. doi:10.1001/archpedi.161.4.384.CrossRef

Szatmari, P., Maziade, M., Zwaigenbaum, L., Merette, C., Roy, M. A., Joober, R., et al. (2007). Informative phenotypes for genetic studies of psychiatric disorders. American Journal of Medical Genetics. Part B, 144, 581–588.CrossRef

Veenstra-Vander-Weele, J., Kim, S., Lord, C., Courchesne, R., Akshoomoff, N., Levinthal, B. L., et al. (2002). Transmission disequillibrium studies of the serotonin 5ht2a receptor gene (htr2a) in autism. American Journal of Medical Genetics, 114, 277–283. doi:10.1002/ajmg.10192.CrossRef

Whitaker-Azmitia, P. (2001). Serotonin and brain development: Role in human developmental diseases. Brain Research Bulletin, 56, 479–485. doi:10.1016/S0361-9230(01)00615-3.PubMedCrossRef

Yatham, L. N., Liddle, P. F., Dennie, J., Shiah, I. S., Adam, M. J., Lane, C. J., et al. (1999). Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: A positron emission tomography study with F¹⁸-labeled setoperone. Archives of General Psychiatry, 56, 705–711. doi:10.1001/archpsyc.56.8.705.PubMedCrossRef

Young, S. N., Leyton, M., & Benkelfat, C. (1999). PET studies of serotonin synthesis in the human brain. Advances in Experimental Medicine and Biology, 467, 11–18.PubMed

Titel: Cortical Serotonin Type-2 Receptor Density in Parents of Children with Autism Spectrum Disorders
Auteurs: Jeremy Goldberg
George M. Anderson
Lonnie Zwaigenbaum
Geoffrey B. C. Hall
Claude Nahmias
Ann Thompson
Peter Szatmari
Publicatiedatum: 01-01-2009
Uitgeverij: Springer US
Gepubliceerd in: Journal of Autism and Developmental Disorders / Uitgave 1/2009
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI: https://doi.org/10.1007/s10803-008-0604-4

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2009

Age-Related Differences in Restricted Repetitive Behaviors in Autism Spectrum Disorders

Validation of the Autism Spectrum Screening Questionnaire in a Total Population Sample

Parents’ Experiences of Home-Based Applied Behavior Analysis Programs for Young Children with Autism

Conversational Behaviors in Youth with High-functioning ASD and Asperger Syndrome

Joint Engagement and the Emergence of Language in Children with Autism and Down Syndrome

Sex Differences in WISC-III Profiles of Children with High-functioning Pervasive Developmental Disorders